Michal Balcerak

Mr. Michal Balcerak

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2024 in Medical Image Analysis
Verified
Journal Article
Closed access
RZRay Zirui Zhang
Ray Zirui Zhang
IEIvan Ezhov
Ivan Ezhov
MBMichal Balcerak
Michal Balcerak
AZAndy Zhu
Andy Zhu
BWBenedikt Wiestler
Benedikt Wiestler
JLJohn S. Lowengrub
John S. Lowengrub

1 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMichal Balcerak
Michal Balcerak
JWJonas Weidner
Jonas Weidner
PKPetr Karnakov
Petr Karnakov
IEIvan Ezhov
Ivan Ezhov
SLSergey Litvinov
Sergey Litvinov
BMBjoern Menze
Bjoern Menze
Brain tumor growth is unique to each glioma patient and extends beyond what is visible in imaging scans, infiltrating surrounding brain tissue. Understanding these hidden patient-specific progressions is essential for effective therapies. Current treatment plans for brain tumors, such as radiotherapy, typically involve delineating a uniform margin around the visible tumor on pre-treatment scans to target this invisible tumor growth. This “one size fits all" approach is derived from population studies and often fails to account for the nuances of individual patient conditions. We present the Glioma Optimizing the Discrete Loss (GliODIL) framework, which infers the full spatial distribution of tumor cell concentration from available multi-modal imaging, leveraging a Fisher-Kolmogorov type physics model to describe tumor growth. This is achieved through the newly introduced method of Optimizing the Discrete Loss (ODIL), where both data and physics-based constraints are softly assimilated into the solution. Our test dataset comprises 152 glioblastoma patients with pre-treatment imaging and post-treatment follow-ups for tumor recurrence monitoring. By blending data-driven techniques with physics-based constraints, GliODIL enhances recurrence prediction in radiotherapy planning, challenging traditional uniform margins and strict adherence to the Fisher-Kolmogorov partial differential equation model, which is adapted for complex cases.